|HIV-1 antiretroviral drug therapy|
EJ Arts, DJ Hazuda
Cold Spring Harbor perspectives in medicine 2 (4), a007161, 2012
|HLA-B57/B* 5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T …|
T Miura, MA Brockman, A Schneidewind, M Lobritz, F Pereyra, A Rathod, ...
Journal of virology 83 (6), 2743-2755, 2009
|A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression|
ME Quiñones-Mateu, SC Ball, AJ Marozsan, VS Torre, JL Albright, ...
Journal of virology 74 (19), 9222-9233, 2000
|Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease|
DM Tebit, EJ Arts
The Lancet infectious diseases 11 (1), 45-56, 2011
|The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates|
KK Ariën, A Abraha, ME Quinones-Mateu, L Kestens, G Vanham, EJ Arts
Journal of virology 79 (14), 8979-8990, 2005
|Is HIV-1 evolving to a less virulent form in humans?|
KK Ariën, G Vanham, EJ Arts
Nature Reviews Microbiology 5 (2), 141-151, 2007
|Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C|
SC Ball, A Abraha, KR Collins, AJ Marozsan, H Baird, ...
Journal of virology 77 (2), 1021-1038, 2003
|Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression|
RM Troyer, KR Collins, A Abraha, E Fraundorf, DM Moore, RW Krizan, ...
Journal of virology 79 (14), 9006-9018, 2005
|Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response|
RM Troyer, J McNevin, Y Liu, SC Zhang, RW Krizan, A Abraha, DM Tebit, ...
PLoS Pathog 5 (4), e1000365, 2009
|Impact of tuberculosis on HIV-1 replication, diversity, and disease progression|
KR Collins, ME Quiñones-Mateu, Z Toossi, EJ Arts
Aids Rev 4 (3), 165-76, 2002
|Human immunodeficiency virus Type 1 nucleocapsid protein (NCp7) directs specific initiation of minus-strand DNA synthesis primed by human tRNA (Lys3) in vitro: studies of viral …|
X Li, Y Quan, EJ Arts, Z Li, BD Preston, H de Rocquigny, BP Roques, ...
Journal of Virology 70 (8), 4996-5004, 1996
|Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.|
EJ Arts, MA Wainberg
Antimicrobial agents and chemotherapy 40 (3), 527, 1996
|Comparison of deoxyoligonucleotide and tRNA (Lys-3) as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reaction.|
EJ Arts, X Li, Z Gu, L Kleiman, MA Parniak, MA Wainberg
Journal of Biological Chemistry 269 (20), 14672-14680, 1994
|Fitness of drug resistant HIV-1: methodology and clinical implications|
ME Quiñones-Mateu, EJ Arts
Drug Resistance Updates 5 (6), 224-233, 2002
|Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.|
X Li, J Mak, EJ Arts, Z Gu, L Kleiman, MA Wainberg, MA Parniak
Journal of Virology 68 (10), 6198-6206, 1994
|HIV-1 fitness: implications for drug resistance, disease progression, and global epidemic evolution|
ME Quiñones-Mateu, EJ Arts
HIV sequence compendium 2001, 134-170, 2001
|HIV diversity, recombination and disease progression: how does fitness “fit” into the puzzle|
DM Tebit, I Nankya, EJ Arts, Y Gao
Aids Rev 9 (2), 75-87, 2007
|Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates|
AJ Marozsan, E Fraundorf, A Abraha, H Baird, D Moore, R Troyer, ...
Journal of virology 78 (20), 11130-11141, 2004
|Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry|
AJ Marozsan, DM Moore, MA Lobritz, E Fraundorf, A Abraha, JD Reeves, ...
Journal of virology 79 (11), 7121-7134, 2005
|Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs|
VS Torre, AJ Marozsan, JL Albright, KR Collins, O Hartley, RE Offord, ...
Journal of Virology 74 (10), 4868-4876, 2000